These discrepancies highlight a critical gap in our understanding, suggesting that the influence of ADIPOQ may be context-dependent, varying with ethnicity, the specific clinical phenotype being examined (e.g., PCOS risk vs. obesity within PCOS), and potential interactions with other genetic and environmental factors. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.